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ABSTRACT We have cloned two splice variants of the human homolog of the 1A subunit of voltage-gated Ca
2 channels.
The sequences of human 1A-1 and 1A-2 code for proteins of 2510 and 2662 amino acids, respectively. Human 1A-22b1b
Ca2 channels expressed in HEK293 cells activate rapidly (10mV  2.2 ms), deactivate rapidly (–90mV  148 s), inactivate
slowly (10mV  690 ms), and have peak currents at a potential of 10 mV with 15 mM Ba
2 as charge carrier. In HEK293
cells transient expression of Ca2 channels containing 1A/B(f), an 1A subunit containing a 112 amino acid segment of 1B-1
sequence in the IVS3-IVSS1 region, resulted in Ba2 currents that were 30-fold larger compared to wild-type (wt) 1A-2-
containing Ca2 channels, and had inactivation kinetics similar to those of 1B-1-containing Ca
2 channels. Cells transiently
transfected with 1A/B(f)2b1b expressed higher levels of the 1, 2b, and 1b subunit polypeptides as detected by
immunoblot analysis. By mutation analysis we identified two locations in domain IV within the extracellular loops S3-S4
(N1655P1656) and S5-SS1 (E1740) that influence the biophysical properties of 1A. 1AE1740R resulted in a threefold increase
in current magnitude, a 10 mV shift in steady-state inactivation, and an altered Ba2 current inactivation, but did not affect
ion selectivity. The deletion mutant 1ANP shifted steady-state inactivation by 20 mV and increased the fast component
of current inactivation twofold. The potency and rate of block by -Aga IVA was increased with 1ANP. These results
demonstrate that the IVS3-S4 and IVS5-SS1 linkers play an essential role in determining multiple biophysical and pharma-
cological properties of 1A-containing Ca
2 channels.
INTRODUCTION
Voltage-gated Ca2 channels play important roles in neu-
rotransmitter release, excitation-contraction coupling, hor-
mone secretion, and a variety of other physiological pro-
cesses. Based on biophysical and pharmacological criteria,
multiple types of Ca2 channels have been identified in
intact neurons (L-, T-, N-, R-, and P/Q-type; Hofmann et al.,
1994; Hess, 1990; Tsien et al., 1991; Swandulla et al., 1991;
Snutch and Reiner, 1992). Consistent with these observa-
tions, molecular cloning and expression studies have iden-
tified at least five genes expressed in the nervous system
that encode the pore-forming 1 subunit, termed 1A, 1B,
1C, 1D, and 1E (for review see Snutch and Reiner, 1992;
Birnbaumer et al., 1994). The 1A gene encodes the pore-
forming subunit of a high-voltage-activated Ca2 channel
that is sensitive to -Aga IVA and -CTx MVIIC (Mori et
al., 1991; Sather et al., 1993). The 1A subunit has also been
shown to interact with the neuronal  subunits 1b, 2, 3,
or 4 (Liu et al., 1996), and these  subunits have been
shown to change biophysical properties of the 1A subunit
(De Waard and Campbell, 1995). These properties, and the
distribution of 1A RNA and protein in mammalian brain,
suggest that P-type Ca2 channels in cerebellar Purkinje
neurons and the Q-type Ca2 channels in cerebellar granu-
lar cells may contain the 1A subunit (Starr et al., 1991;
Llinas et al., 1992; Mintz et al., 1992a, b; Randall and Tsien,
1995; Sather et al., 1993; Stea et al., 1994; Westenbroek et
al., 1995; Tottene et al., 1996). However, the biophysical
and pharmacological properties of P- and Q-type and re-
combinant 1A-containing Ca
2 channels do not precisely
correlate; this discrepancy might be a result of differences in
their structure and subunit composition.
Recent studies indicate that the levels of functional ex-
pression of recombinant Ca2 channels can differ signifi-
cantly. For example, functional expression of recombinant
Ca2 channels containing rat 1B in Xenopus oocytes is
relatively poor compared to those containing a rabbit 1A
subunit (Mori et al., 1991; Ellinor et al., 1994). We found
that human 1B-1-containing Ca
2 channels can be ex-
pressed efficiently in HEK293 cells, as indicated by the
number of -CgTx-GVIA binding sites and robust current
magnitude (Brust et al., 1993; Williams et al., 1992),
whereas functional expression of human 1A-2-containing
Ca2 channels in HEK293 cells is markedly lower.
In this work we describe the cloning of cDNAs encoding
two structural variants of the human 1A Ca
2 channel
subunit and examine biophysical properties of the 1A-2
variant in combination with human 2b and 1b subunits in
HEK293 cells. In addition, we constructed 1A/B chimeras
and 1A mutations to identify regions in the 1A subunit
amino acid sequence that control current magnitude, gating
properties, and sensitivity to -Aga IVA. Preliminary com-
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munications of some of this work have been published (Zahl
et al., 1994; Williams et al., 1995).
MATERIALS AND METHODS
cDNA libraries
Recombinant cDNA libraries were prepared in the phage vector gt10
essentially as described (Gubler and Hoffman, 1983; Lapeyre and Amalric,
1985). Two human cerebellum libraries were constructed from poly(A)-
selected RNA: 1) random-primed, 1.0 kb, and 2) specifically primed
(primer is the complement of human 1A nt 2485 to 2510), 2.0 kb.
Isolation of cDNAs
Approximately 2  106 recombinants of the random-primed library were
screened with a combination of oligonucleotide probes based on the rat 1A
sequence: oligonucleotide 1, complementary to rat nt 767 to 796; oligo-
nucleotide 2, rat nt 2288 to 2315; oligonucleotide 3, rat nt 3559 to 3585;
oligonucleotide 4, rat nt 4798 to 4827; and oligonucleotide 5, rat nt 6190
to 6217. Clones 1.244 (human nt 5131 to 7555), 1.254 (human nt 5686 to
8400), 1.274 (human nt 2287 to 4001), and 1.278 (human nt 2871 to
4968) were identified and characterized. Oligonucleotides 1 and 2 were
used to screen 8  105 recombinants of the specifically primed library.
Clone 1.381 (human nt 236 to 2510) was isolated and characterized. All
cDNAs were subcloned into pGEM7Z (Promega, Madison, WI). The DNA
sequence was determined by the dideoxy chain-termination method using
Sequenase 2.0 (USB, Cleveland, OH) or with an Applied Biosystems 373A
automated DNA sequencer and the Taq DyeDeoxy terminator cycle se-
quencing kit (Applied Biosystems, Foster City, CA).
Full-length construct
To facilitate the construction of a full-length 1A cDNA, two fragments
were amplified from human cerebellum total RNA by polymerase chain
reaction (PCR). pcDNA1A-1 was constructed in pcDNA1 (Invitrogen, San
Diego, CA) using 1.381 (nt 236 to 2267), PCR fragment 1 (nt 2267 to
2879), 1.278 (nt 2879 to 4939), PCR fragment 2 (nt 4939 to 5282), and
1.244 (nt 5282 to 7555). For pcDNA1A-2 the BglII/SalI fragment of 1.254
(1A-2 nt 5879 to 7143) replaced the corresponding 1.244 fragment.
Chimera/mutation constructions
The full-length 1A (pcDNA1A-2) and 1B (pcDNA1B-1) constructs were
described previously and are denoted in this section as 1A-2 and 1B-1,
respectively. Chimeras between 1A-2 and 1B-1 in the pcDNA1 expression
vector (Invitrogen, San Diego, CA) are designated 1A/B(a)–1A/B(f) and
were constructed as follows:
1A/B(a): A PCR primer containing the mutations C5232G and A5233C
that creates an SphI site in the 1B-1 sequence was used to amplify a
fragment of 1B-1 from 5217 to 5622. An SphI(5233)-KpnI(5525) fragment
of the PCR product and a KpnI(5525)-XbaI(7177) fragment of 1B-1 were
introduced into 1A-2 at the unique SphI(5557)-XbaI (3	 polylinker) sites.
1A/B(b): A BamHI (5	 polylinker)-KpnI (4459A) fragment of 1A-2 was
ligated into the BamHI (5	 polylinker)-KpnI (5304B) sites of 1B-1.
1A/B(c): A PCR primer with mutation T4650C creating an EcoRV site
in the 1B-1 sequence was used to amplify a fragment of 1B-1 from 4632
to 5334. An EcoRV-XhoI (5304) fragment of the PCR product and an
XhoI-XbaI fragment of 1B-1 were introduced into the corresponding
region of 1A-2 at the unique EcoRV (4942) and XbaI (3	 polylinker) sites.
1A/B(d): PCR primers with mutation T4650C creating an EcoRV site in
addition to C5232G and A5233C creating an SphI site in the 1B-1 se-
quence were used to amplify a fragment of 1B-1 from 4632 to 5244. The
PCR product was introduced into the corresponding region of 1A-2 at the
unique EcoRV (4942) and SphI (5557) sites.
1A/B(e): PCR primers with mutations G4965A and C4968T creating a
HinDIII site in addition to C5232G and A5233C creating an SphI site in the
1B-1 sequence were used to amplify a fragment of 1B-1 from 4957 to
5244. The PCR product was introduced into the corresponding region of
1A-2 at the unique HinDIII (5283) and SphI (5557) sites.
1A/B(f): Mutagenic PCR primers with mutation T4650C creating an
EcoRV site in addition to G4965A and C4968T creating a HinDIII site in
the 1B-1 sequence were used to amplify a fragment of 1B-1 from 4632 to
4980. The PCR product was introduced into the corresponding region of
1A-2 at the unique EcoRV (4942) and HinDIII (5283) sites.
Individual point mutations were made using PCR. For the 1A-2 muta-
tions partially overlapping, complementary PCR primers containing the
silent mutation G5205A and introducing an EcoRI site in the 1A-2 se-
quence were used to direct the amplification of two adjoining 1A-2
fragments encompassing nts 4928–5211 and 5200–5751. One of the
fragments also contained the desired point mutation. The two fragments
were ligated into the unique EcoRV (4942) and SphI (5557) sites of 1A-2.
For the 1B-1 mutation, a mutagenic PCR primer was used to amplify a
fragment of 1B-1 from nt 4860–5334. An SphI (4870)-XhoI (5304) frag-
ment of the PCR product was introduced into the SspI and XhoI sites of
1B-1. All chimeras and point mutations were confirmed by DNA sequenc-
ing. The NP construct was generated by the overlap extension method of
the PCR (Ho et al., 1989). An EcoRV (4942)–HinDIII (5283) fragment
containing deletion of nucleotides 4963–4968 was ligated into EcoRV and
HinDIII sites of 1A-2.
Expression
All human 1 subunit cDNAs [wild-type (wt), chimera, mutants] were
transiently coexpressed with human 2b and 1b subunit cDNAs in
HEK293 cells. Transfections were performed using a standard calcium
phosphate-mediated procedure as described previously (Williams et al.,
1994; Brust et al., 1993).
Immunoblot analysis
Total membrane fractions were prepared essentially as described elsewhere
(Perez-Reyes et al., 1989). Briefly, cells from five or six 10-cm dishes were
rinsed with ice-cold, 50 mM Tris/pH 7.2, 1 mM EDTA, resuspended in 12
ml of the rinse buffer supplemented with a cocktail of protease inhibitors
(PI) containing aprotinin (2.0 g/ml), leupeptin (2.0 g/ml), pepstatin (2.0
g/ml), benzamidine HCl (4.0 mM), calpain inhibitor I (5 g/ml), calpain
inhibitor II (5.0 g/ml), and phenylmethylsulfonyl fluoride (500 M) and
homogenized in a Kontes glass/Teflon homogenizer (15 strokes). The
suspension was centrifuged at 400  g for 5 min at 4°C. The pellet was
resuspended in 12 ml ice-cold buffer/PI, rehomogenized, and recentri-
fuged. The supernatants from the two low-speed spins were combined and
centrifuged at 100,000  g for 30 min at 4°C. The pellet was resuspended
in 0.5 ml of 50 mM Tris/pH 7.2, 1 mM EDTA, PI. The total yield of
membrane protein was typically 2–3 mg.
Proteins were separated by SDS-PAGE on 4–12% gradient gels and
transferred to nitrocellulose filters (Hybond, Amersham, Arlington
Heights, IL). Specific protein bands were detected by the ECL detection
method according to the manufacturer’s instruction.
The 1A subunits were detected using polyclonal antisera, whereas 2
and 1b subunits were visualized by monoclonal antibodies (supplied by
W. Smith, Lilly Research Centre Limited, Erl Wood Manor, Windlesham,
Surrey, UK).
Electrophysiology
Functional expression of recombinant Ca2 channels in transfected cells
was evaluated 48 h after transfection using the whole-cell patch clamp
technique (Hamill et al., 1981). Transfected cells were identified by FDG
staining (Molecular Probes, Inc., Eugene, OR) or with CD4 antibody-
coated Dynabeads (Dynal, A.S., Oslo, Norway). Whole-cell currents were
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recorded using an Axopatch-200A (Axon Instruments, Foster City, CA) or
an EPC-9 (HEKA elektronik, Lambrecht, Germany) patch clamp amplifier,
low-pass filtered at 1 kHz (3 dB, 8-pole Bessel filter) and digitized at a
rate of 10 kHz unless otherwise stated. For tail current measurements,
electrodes were coated with Sylgard (Dow Corning, Midland, MI), super-
charging was applied to reduce the expected charging time constant for the
cells to 
4 s, and the digitization/filter rates were 50/16 kHz. Linear leak
and residual capacitive currents were digitally on-line subtracted using a
P/4 protocol. The holding potential was (Vh) 90 mV unless otherwise
noted. Steady-state inactivation was determined from a holding potential of
100 mV by a test pulse to 10 mV (p1), followed by a 20-s prepulse
from 100 mV to 20 mV in 10-mV decrements (pHold) preceding a
second test pulse to10 mV (p2). The digitization rate was 0.5 kHz during
p1 and pHold and 2.5 kHz during p2. Pipettes were manufactured from
TW150 glass (WPI, Sarasota, FL) and had resistance of 1.1–1.4 M when
filled with internal solution. Series resistance was 2–4 M and 70–95%
series resistance compensation was generally used. The pipette solution
contained (in mM): 135 CsCl, 10 EGTA, 1 MgCl2, 10 HEPES (pH 7.3,
adjusted with TEA-OH). The external solution contained (in mM): 15
BaCl2, 150 choline chloride, 5 TEA-Cl 1 MgCl2, and 10 HEPES (pH 7.3,
adjusted with TEA-OH). In studies where the external Ca2 concentration
was 15, 0.3, or 0 mM, the solution contained (in mM): 120 NaCl, 10
HEPES, and 15 or 0.3 CaCl2 or 10 EGTA, respectively. All recordings
were performed on single cells at room temperature (19–24°C). All values
given as mean  SD unless otherwise stated. Differences between the wt
1A-2 and mutant 1A subunits in current magnitude (or fold increase) and
inactivation kinetics were tested for statistical significance by an analysis
of variance (ANOVA) followed by a post-hoc Dunnett’s test (SigmaStat
1.01, Jandel Scientific). Statistical analysis revealed identical results for
comparison of current amplitudes and fold increase, thus in the text only
statistical values for fold increase are shown. All reagents were obtained
from Sigma Chemical Co. (St. Louis, MO). The peptide toxin -Aga IVA
was obtained from Pfizer Inc. (Groton, CT) and all -Aga IVA containing
solutions also contained 1 mg/ml cytochrome c.
RESULTS
Cloning and functional expression of the human
1A Ca
2 channel subunit
Overlapping cDNAs encoding the entire human neuronal
1A subunit were isolated and sequenced. The translation
initiation site was assigned to the first methionine that
appears downstream of an in-frame nonsense codon (1A nt
120 to 118). The 1A subunit shares the same predicted
transmembrane topography as described previously for
other Ca2 channel 1 subunits (Catterall et al., 1993). After
characterizing human cDNAs we identified nucleotide al-
terations near the COO-terminus that result in the expres-
sion of two 1A isoforms, 1A-1 and 1A-2. The sequence of
cDNAs encoding the 1A-2 variant contained a five-nucle-
otide (nt) deletion relative to 1A-1 (1A-1 nt 6799 to 6803)
that produces an in-frame nonsense codon immediately
following the deletion, and results in a truncated COOH-
terminus in the protein. These nucleotide alterations likely
result from alternative RNA splicing. The human 1A-1 and
1A-2 variants encode for proteins containing 2510 and 2266
amino acids with a predicted molecular weight of 282,873
and 257,440, respectively. The 1A sequences contain a
33-nt CAG repeat near the COO terminus that encodes 11
consecutive glutamine residues (Q) in the 1A-1 sequence.
In 1A-2 the CAG repeat lies within the 3	 untranslated
region as it occurs after the 5-nt deletion that results in the
shorter COO terminus. The 1A-1 variant is 99.3% iden-
tical to the human isoform BI–1-GGCAG described by
Zhuchenko et al. (1997) and is 92.1 and 91.3% identical to
the rabbit BI-2 and rat rbA-1 isoforms (Mori et al., 1991;
Starr et al., 1991). The 1A-2 variant is 99.5 and 99.1%
identical to the human isoforms BI–1 and CACHL1A4
(Zhuchenko et al., 1997; Ophoff et al., 1996), has 94.8%
identity to rabbit BI-1 (Mori et al., 1991), and 93.7% to rat
rbA (Starr et al., 1991). Ophoff et al. (1996) did not describe
the longer form of 1A that corresponds to the human 1A-1
variant.
There are several important differences between the 1A
sequences described by Ophoff et al. (1996) and Zhuchenko
et al. (1997) and the sequence reported here. First, the
sequence described here contains insertions of amino ac-
id(s) in the domain II-III linker (VEA at 726–728, E at
1204) and in the IVS3-S4 linker (NP at 1655–1656) that
were not described by Ophoff et al. (1996) or Zhuchenko et
al. (1997). Second, the sequence described here and that
described by Zhuchenko et al. (1997) is identical at loca-
tions 899(D; II-III loop), 1462(G; IIIS5-S6 linker), 1607
(V), and 1620 (V; IVS2), but differs from that described by
Ophoff et al. (1996) (D8993G, G14623A, V16073A,
V16203A). Third, at 10 locations within the COO-terminus
the sequences described by Ophoff et al. (1996) and
Zhuchenko et al. (1997) are identical but differ from those
described here (W18493C, M18523 I, P18533H, L18553K,
Q18593S, M18603L, H18633V, M18643 I, A18763H,
Y18803C).
The identified 1A sequence was confirmed by the isola-
tion and characterization of multiple cDNA clones or PCR
products from a single source. Based on the genomic se-
quence presented by Ophoff et al. (1996) the insertion of
amino acid residues VEA in the II-III linker is likely due to
the selection of alternate splice acceptor sites. Some of the
differences in amino acid sequence determined in the three
studies may represent additional splice variants of 1A (see
below).
We examined the biophysical properties of Ca2 chan-
nels in HEK293 cells after transient transfection with
cDNAs encoding human 1A-2, 2b, and 1b subunits.
Currents recorded from cells in an external solution con-
taining 15 mM Ba2 as charge carrier were rapidly activat-
ing (Fig. 1 A) and slowly inactivating (Fig. 1 B). Peak
inward currents were maximal at test potentials between
10 and 20 mV, and no inward current was observed at
80 mV (Fig. 1 C). Currents were also detected with Ca2
channels containing the 1A-1 splice variant (data not
shown), thus both splice variants we have isolated can be
functionally expressed. In this study we have focused on
characterization of the 1A-2 splice variant.
We investigated the voltage-dependence of activation and
deactivation kinetics of 1A-22b1b Ca
2 channels. The
time constant for the voltage-dependence of activation was
determined by fitting a single exponential to the onset of the
current trace. For membrane potentials between 20 and
10 mV the average value of the activation time constant
1386 Biophysical Journal Volume 76 March 1999
FIGURE 1 Biophysical properties of Ba2 currents recorded from 1A-22b1b Ca
2 channels in HEK293 cells. (A) Examples of current traces elicited
by 150-ms test pulses from a holding potential of90 mV to between50 mV and10 mV, top panel, and between20 mV and80 mV, bottom panel.
(B) Examples of current traces elicited by 2-s test pulses from a holding potential of 90 mV to between 30 mV and 0 mV, top panel, and between 10
mV and 30 mV, bottom panel. (C) Current-voltage relationship from traces, as in (A) normalized to the peak current in each cell and averaged. Points
represent the mean  SD (n  6). (D) The time constant for kinetics of activation of IBa determined by fitting the rising phase of the current with a single
exponential is plotted against the test potential. Data points represent the mean  SD (n  5). (E) Time constant for kinetics of deactivation determined
by the single exponential fit of the tail current. Tail currents were elicited by repolarizations to voltages ranging from 100 to 60 mV after a brief
depolarization to 60 mV. (F) Voltage-dependence of activation (m) and isochronal inactivation (h). The amplitude of tail currents was determined by
extrapolating the tail current to the time of the end of the test pulse. Normalized tail current amplitudes were plotted (open symbols, mean  SD) versus
test potential. Data were fitted by a Boltzmann function m  [1  exp((Vtest  V1/2)/k)]
1, V1/2  9.5 mV, k  12.8 mV, n  5. Isochronal
inactivation was determined from a holding potential of 100 mV by a test pulse to 10 mV (p1), followed by a 20-s prepulse from 100 mV to 20
mV in 10 mV decrements (pHold) preceding a second test pulse to 10 mV (p2). Normalized current amplitudes were plotted (closed symbols, mean 
SD) versus holding potential. Data were fitted by a Boltzmann function h  [1  exp((Vhold  V1/2)/k)]
1, V1/2  17 mV, k  8.6 mV, n  5.
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was 2.2 ms (at 10 mV: 2.17  1.1 ms, n  8) and it
declined at more depolarized potentials (20 to 60 mV),
reaching 0.6 ms at 60 mV (Fig. 1 D). The voltage-
dependence of deactivation kinetics was determined by tail-
current analysis by fitting a single exponential to the decay
of the tail current (Fig. 1 E). The average deactivation time
constant at 90 mV was 148  34 s (n  6) for the
1A-22b1b Ca
2 channel, a value similar to that reported
for native and recombinant HVA Ca2 channels (Matteson
and Armstrong, 1986; Williams et al., 1994; Bleakman et
al., 1995).
We further determined isochronal inactivation (h) and
steady-state activation (m). Isochronal inactivation of
1A-22b1b Ca
2 channels (Fig. 1 F) was determined
using a 20-s inactivating prepulse. The voltage-dependence
of activation, or steady-state activation (m), of 1A-
22b1b Ca
2 channels was determined from tail currents
elicited at different test potentials. The voltage for half-
maximal inactivation (V1/2) was 17 mV, 30 mV less
negative than human 1B or 1E recombinant HVA Ca
2
channels, and the V1/2 for activation was 9.5 mV (Fig.
1 F), which is similar to other HVA Ca2 channels (Wil-
liams et al., 1994; Bleakman et al., 1995).
Ca2 channels containing 1A/B chimeras
Transient transfection of the human 1A-2 or 1B-1 calcium
channel subunits with the human 2b and 1b subunits in
HEK293 cells resulted in functional expression of Ca2
channels with distinct biophysical properties. Cells express-
ing 1B-1-containing Ca
2 channels had robust voltage-
activated Ba2 currents (Fig. 2 A, 2712  830 pA, n  25),
whereas currents from 1A-2-expressing cells were 15-
fold smaller (Fig. 2 A, 185 161 pA, mean SD, n 73).
The current-voltage relationships for 1A-2- and 1B-1-con-
taining Ca2 channels were very similar with current
thresholds at 40 mV, maximum current at 10 mV, and
reversal of currents positive to 70 mV (Fig. 2 A). Both
Ca2 channels also have very similar activation kinetics
(act(10mV) 1A-2: 2.17 1.1 ms, n 8; 1B-1: 2.31 0.89
ms, n 5) but differ markedly in their inactivation kinetics.
The 1B-1-containing channel inactivates 2-fold faster
than the 1A-2-containing channel (Fig. 2 B, see below), and
the two channels differ in their V1/2 of isochronal inactiva-
tion by 42 mV (Fig. 1 F; Bleakman et al., 1995).
To determine whether discrete structural elements of the
1A-2 subunit are responsible for these differences in the
current magnitude, a series of 1A/B chimeras were con-
structed using an 1A-2 backbone and evaluated in transient
expression experiments with the human 2b and 1b sub-
units. Based upon recent studies suggesting that COO-
terminal sequences of the 1C subunit influence Ca
2 chan-
nel current magnitude (Wei et al., 1994), construction of
chimeras was initially focused on the COO terminus of 1A-2.
In the first 1 chimera, designated 1A/B(a), the COO

terminus of the wt human 1A-2 subunit was replaced with
the corresponding human wt 1B-1 sequence (Fig. 3 A). The
magnitude of Ba2 current from cells expressing 1A/B(a)
was similar to that from cells expressing the wt 1A-2
subunit (Fig. 3 B, n 12; p 0.3), indicating that the 1A-2
COO terminus was not responsible for the differences in
current magnitude. The second chimera, 1A/B(b), contained
1B-1 sequence from IIIS6 to the COO
 terminus (Fig. 3 A).
The current magnitude in cells expressing the 1A/B(b) sub-
unit was significantly larger (29.2  17.2-fold, n  4; p 

0.05) than in cells expressing the wt 1A-2 subunit (Fig. 3
B). These data suggested that amino acid sequences between
IIIS6 and the COO terminus were critical for the observed
increase in current magnitude, and 1A/B(c) through 1A/B(f)
were constructed to localize the critical region. Substitution
of 1B sequence from IVS3 to the COO
 terminus (1A/B(c))
also significantly increased current magnitude (10.1  5.4-
fold, n  4; p 
 0.05). In 1A/B(d), narrowing the 1B
sequence to the IVS3 to IVS6 region resulted in a signifi-
cant increase in current magnitude (23.6 12.9-fold, n 4;
p 
 0.05). Finally, the role of the putative pore-forming
region in repeat IV was also investigated by construction of
1A/B(e) and 1A/B(f), each replacing approximately one-half
of the 1A-2 pore-forming region with the corresponding
1B-1 sequence (Fig. 3 B). Replacement of the IVSS2 to
IVS6 segment with 1B-1 sequence (1A/B(e)) resulted in
Ca2 channels with current magnitudes similar to those
containing wt 1A-2. In contrast, replacement of the 1A-2
IVS3 to the end of the IVSS1 segment with the correspond-
ing 1B-1 sequence (1A/B(f)) resulted in a significant in-
crease in current magnitude (28.3  25.1-fold, n  14; p 

0.05; Fig. 3 B).
FIGURE 2 Comparison of the current-voltage and kinetic properties of
1A-22b1b and 1B-12b1b calcium channels expressed in HEK293
cells. (A) Average current-voltage relationships from cells expressing hu-
man 1A-22b1b and 1B-12b1b Ca
2 channels. Data points represent
the mean SD (n 6). (B) Normalized current traces illustrate similarities
in activation kinetics and differences in inactivation kinetics for
1A-22b1b and 1B-12b1b Ca
2 channels. Currents were elicited by
step depolarizations to 10 mV from a holding potential of 90 mV.
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Identification of amino acids in domain IV of the
1A subunit involved in the control of
biophysical properties
These results limited the critical region responsible for
increasing current magnitude to the IVS3 to IVSS2 region
encompassing a region of 112 amino acids (Fig. 4 A). There
are 20 amino acid differences between 1A-2 and 1B-1
subunits within this region and all of these are located in
putative extracellular loops. Based on a comparison of 1A-2
with other classes of known human neuronal 1 sequences
(Fig. 4 A), 13 of these 20 amino acids with nonconservative
changes could be further subdivided into three groups that
might be responsible for the effects observed in the chime-
FIGURE 3 Chimeras of human 1A-2 and 1B-1 Ca
2 channel subunits. (A) The predicted transmembrane topography of the 1 subunit of voltage-
dependent calcium channels. Human 1A/1B chimeras were constructed by substituting various segments of 1B sequence within the corresponding COO

region of the 1A subunit (boxed region). (A) (a–f): Models of 1A/B(a)-1A/B(f); the thin lines and open boxes represent 1A sequences and the heavy lines
and filled boxes represent 1B sequence. (B) Comparison of maximum inward current magnitude for recombinant Ca
2 channels containing 2b1b with
1A-2, 1B-1, or 1A/B(a)-1A/B(f). Maximum inward barium currents were normalized with respect to that of the 1A-22b1b Ca
2 channel. Data points
represent mean  SD and the n values for the individual experiment are given in parentheses above the bar. , values significantly different from control
(1A-22b1b) at p 
 0.05. Shaded boxes at left represent 1B sequence, whereas open boxes represent 1A sequence.
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ras: 1) a cluster of four contiguous amino acids located
within the extracellular linker between IVS3 and IVS4
which included changes in size and charge, 2) an additional
eight contiguous amino acids in the extracellular loop link-
ing IVS5 and IVSS1, which adds six negative charges and
length to the IVS5-IVS6 linker, and 3) a glutamate residue
at position 1740, also in the putative IVS5-IVSS1 extracel-
lular loop (Fig. 4 A). The negatively charged glutamate at
position 1740 is unique to 1A subunits; all other 1 sub-
units have a positively charged arginine at the equivalent
position. Interestingly, the glutamate at position 1740 is
conserved among all cloned 1A subunits (rat, rabbit, and
human) whereas all other cloned 1 subunits (1B–1E and
1S) have an arginine at the corresponding position (rat,
rabbit, human, ray, mouse, hamster, Drosophila, and carp).
To limit the number of mutations, we altered each of the
three amino acid groupings in the wt 1A-2 subunit individ-
ually by site-directed mutagenesis to the corresponding
1B-1 sequence. The resulting three constructs are desig-
nated 1AIAET1653-56, deletion 1A1726-33, and the
single-point mutation 1AE1740R (Fig. 4 A). The other
seven amino acid differences in this region between 1A and
1B that were considered conservative changes were not
addressed in this study.
Transient expression experiments with 1AIAET1652-56
or 1A1726-33 resulted in functional calcium channels,
but neither construct enhanced the current magnitude to the
level of the wt 1A-2-containing Ca
2 channel (Fig. 4 C). In
contrast, exchange of the negatively charged glutamate for
the positively charged arginine at position 1740 (E1740R)
of the 1A-2 subunit significantly enhanced the current mag-
nitude (3.2  1.75-fold, n  14; p 
 0.05) compared to
results with wt 1A-2. The specificity of the enhancement
observed with the 1AE1740R mutation is shown by the
reverse mutation 1AE1740R/R1740E, which restored the
current magnitude to that of the wt 1A-2-containing Ca
2
channel. Exchange of glutamate for the neutral amino acids
glutamine (1AE1740Q) or alanine (1AE1740L) had no
detectable effect on current magnitude (Fig. 4 C). Interest-
ingly, introduction of the mutation analogous to 1AE1740R
in the 1B-1 subunit (R1634E), followed by transient coex-
pression with the 2b and 1b subunits, resulted in Ca
2
channels with current magnitudes and kinetics similar to
cells expressing the wt 1B-1 subunit (1.0  0.4-fold in-
crease, n  4; data not shown). These experiments demon-
strate that an arginine residue in the IVS5-IVS6 linker is
important for current enhancement in Ca2 channels con-
taining the 1A-2 but not the 1B-1 subunit.
The IVS3-SS1 region in the human 1A clone that seems
critical for current enhancement has two additional amino
acids (N1655P1656) that are not found in rabbit, mouse, or the
two recently described human 1A clones (Mori et al., 1991;
Fletcher et al., 1996; Zhuchenko et al., 1997; Ophoff et al.,
1996). To test whether deletion of N1655P1656 could produce
enhancement in current magnitude similar to 1A/B(f) we
constructed the deletion mutant 1ANP (Fig. 4 B). Tran-
sient expression of 1ANP resulted in functional calcium
channels with current magnitude similar to that of wt
1A-2-containing Ca
2 channels (Fig. 4 C), but with signif-
icantly altered biophysical and pharmacological properties
(see below).
Expression of polypeptides representing chimera
1A/B(f) and mutation 1AE1740R
To determine whether the increase in current magnitude
observed with 1A/B(f)- or 1AE1740R-containing Ca
2
channels resulted from an increase in the levels of Ca2
channel subunit proteins in the cell membrane, we used
immunoblot analysis to compare the levels of protein ex-
pression of the 1, 2b, and 1b subunits. Subunits were
detected by immunostaining with polyclonal antisera spe-
cific to the 1A subunit or monoclonal antibodies specific to
the 2 and 1b subunits (Fig. 5 A). Although there was no
detectable 1A or 1b protein in untransfected HEK293
cells, there appeared to be a very low level of 2 protein
expressed in these cells (Fig. 5 A). The protein levels of the
1 and the 1b subunits were moderately elevated in cells
expressing the 1AE1740R subunit compared to those ex-
pressing wt 1A-2, averaging increases of 2.1- and 2.0-
fold, respectively, as determined by densitometric analysis
of the immunoblot (Fig. 5 B). A more substantial increase in
protein level was observed in cells expressing 1A/B(f),
FIGURE 4 Involvement of amino acid residues in the IVS3 to IVS6 region of the human Ca2 channel 1A-2 subunits in determining current amplitude.
(A) An alignment of the human neuronal 1A-1E subunit amino acid sequences through the IVS3-IVS6 transmembrane segments showing only those
residues in 1B-1E that differ from 1A. Dots represent gaps introduced to optimize the alignment. Putative transmembrane segments are enclosed in boxes
and the putative pore-lining SS1/SS2 region is indicated by brackets above. 1A/B(f) contains a substitution of amino acids 1648 to 1761 in 1A (indicated
by the two arrows) with the corresponding region of the 1B subunit. Three points of nonconservative difference were identified between 1A and 1B in
this 112-amino acid region and were, therefore, targeted for in vitro mutagenesis: 1A F1653GNP1656 (IAET1653-56), V1726EDEDSDE1733 (1726-33), and
E1740 (E1740R). These amino acids are enclosed in shaded boxes in the 1A-2 sequence. All amino acids are located within putative extracellular loops.
(B) Comparison of the IVS3-S4 spanning region for various neuronal 1A and 1B sequence. Dark shading represents the positions of residues that when
absent in 1A or 1B subunits alter kinetic properties, and in 1A -Aga IVA affinity. 1ANP corresponds to neuronal 1A variants found in human, rat,
and rabbit (Zhuchenko et al., 1997; Ophoff et al., 1996; Starr et al., 1991; Mori et al., 1991). 1BET corresponds to neuronal 1B variant found in rat and
rabbit (Lin et al., 1997; Fujita et al., 1993; Dubel et al., 1992, 1994). (C) Comparison of maximum inward current magnitude for recombinant Ca2 channels
containing 2b, 1b, and either wt 1A-2, 1AE1740R, 1A1726-33, 1AE1740Q, 1AE1740L, 1AIAET1653-56, 1A1726-33/E1740R, or 1AE1740R/
R1740E. Maximum inward barium currents were normalized with respect to that of the 1A-22b1b Ca
2 channel. Data points represent mean  SD and
the n values for the individual experiment are given in parentheses above the bar. , values are significantly different at p 
 0.05 compared to the
1A-22b1b Ca
2 channel.
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where the average increase was 5-fold for the 1A/B(f) sub-
unit and 11-fold for the 1b subunit. The protein levels of
the 2b subunit in cells transfected with 1AE1740R or
1A/B(f) increased only slightly, exhibiting 1.6- and 2.3-fold
increases, respectively (Fig. 5 B). Thus, the increase in
steady-state protein levels of the 1, 2b, and 1b subunits
within the membranes of cells expressing 1A/B(f) or
1AE1740R appears to correlate with the observed increase
in current magnitude; however, it seems unlikely that
changes in the biophysical properties (see below) of Ca2
channels containing 1A/B(f) or 1AE1740R described below
can be entirely attributable to these increases.
Biophysical properties of 1A/B(f), 1AE1740R,
and 1ANP
To further understand the effects of 1A/B(f), 1AE1740R,
and 1ANP mutant subunits on Ca
2 channel function, the
biophysical properties of Ca2 channels containing these
subunits were examined in more detail. Fig. 6, A–C illus-
trates representative Ba2 currents and the resulting current-
voltage relationship of cells transiently expressing Ca2
channels containing the 1AE1740R or 1ANP subunit.
Inward currents were elicited at potentials 30 mV,
peaked at 10 mV, and reversed at potentials positive to
80 mV. The current-voltage relationships for Ca2 chan-
nels containing 1A/B(f) (data not shown) were very similar
to those for channels containing wt 1A-2 or 1B-1 subunits
(see Fig. 2 A).
In contrast to the current-voltage properties, the activa-
tion and the inactivation kinetics of channels containing
1A/B(f), 1AE1740R, and 1ANP subunits differed sub-
stantially from those containing wt 1A-2. The Ba
2 currents
recorded from channels containing 1A/B(f) or 1ANP ac-
tivated faster than those from channels containing the wt
1A-2 subunit (act,10 mV; 1A/B(f): 1.49 0.4 ms, p 0.07;
1ANP: 1.24  0.48 ms, p 
 0.05; wt 1A-2: 2.17  1.1
ms; n  10, 7, and 8, respectively; Fig. 6 D), whereas
currents from channels containing 1AE1740R had activa-
tion kinetics identical to the wt 1A-2 (2.1  0.26 ms; n 
8; p  0.15; Fig. 6 D). Similar results were also observed at
different test potentials between10 and40 mV (data not
shown). The time course of inactivation was also altered
with 1A/B(f), 1AE1740R, and 1ANP compared to wt 1A
(Fig. 6 D) and the rate of inactivation was evaluated during
2-s depolarizations (Fig. 7). Inactivation kinetics were more
FIGURE 5 Immunoblot analysis of the expression of recombinant Ca2 channel subunit polypeptides. (A) Immunoblot analysis of Ca2 channel subunit
polypeptides levels in membranes isolated from HEK293 cells transiently transfected with cDNAs encoding human 2b and 1b together with 1A-2,
1A/B(f), 1AE1740R subunits or from untransfected cells. The different 1 subunits are indicated above each lane. Filters were cut horizontally above the
148 kDa marker to allow identification of all three subunits on the same gel. Membrane proteins (30 g per lane) were immunostained with affinity-purified
1A polyclonal antisera (top panel) or monoclonal antibodies (mAb) specific for the 2 or 1b subunits (bottom panel). Since the polypeptides were
separated under reducing conditions the 2b subunit was dissociated from the  subunit. Previous experiments indicate that the mAb for 2 and 1b do
not cross-react (data not shown). The Ca2 channel subunits are denoted with arrows. Quantitative analysis of expression levels of specific Ca2 channels
subunits is illustrated in (B). Values represent the amount of membrane protein obtained from total membranes in two separate sets of transfections. The
data were normalized with respect to those obtained in the wt 1A-2 transfection. All transfection efficiencies were approximately equivalent (50–60%)
as determined by X-gal staining.
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rapid in 1B-1- than 1A-2-containing Ca
2 channels (Fig. 7
A) and in both cases were best fit with the sum of two
exponential functions. The time constant for the fast com-
ponent (1) was 2-fold faster for 1B-1 compared to wt
1A-2-containing Ca
2 channels (89  13 vs. 179  36 ms,
p 
 0.001, n  12) while the time constant for the slow
component (2) was similar (see Table 1). The inactivation
kinetics for 1AE1740R-containing channels were qualita-
tively similar to those of channels containing wt 1A-2 (Fig.
7 B), but were best fit by a single exponential function. In
contrast, the inactivation of 1ANP was similar to that of
channels containing the wt 1B-1 subunit (Fig. 7 C, Table 1).
The rate of inactivation was even further increased in
1A/B(f)-containing channels, which contains both mutations
(Fig. 7 D). Similar differences in inactivation kinetics were
observed for test potentials between 0 and 40 mV (data
not shown). The faster rate of inactivation observed with
1B or 1A/B(f) is most likely a voltage-dependent rather
than a calcium-dependent process, as there is no correlation
between rate of inactivation and current magnitude in the
range from 2 to 18 nA. (r2  0.05, Vtest 0–30 mV, n 
10). These results indicate that amino acids N1655P1656 are
important in determining the activation and inactivation
kinetics of the channel. The further increase in rate of
inactivation with 1A/B(f) indicates that additional amino
acids within the IVS3-S4 and/or the IVS5-SS1 linker are
important in determining inactivation kinetics.
Ca2 channels containing 1A/B(f), 1AE1740R, or
1ANP also displayed altered isochronal inactivation
properties compared to those containing the wt 1A-2 sub-
unit. Using a 20-s conditioning pulse, the V1/2 of inactiva-
tion for 1A-2- and 1B-1-containing channels was 17 mV
and 59 mV, respectively (Fig. 8 A). Ca2 channels con-
taining 1AE1740R or 1ANP had a V1/2 of 27 or 37
mV, respectively, corresponding to a shift of 10 or 20
mV compared to those containing the wt 1A-2 subunit. The
V1/2 value for channels containing 1A/B(f) was 42 mV, a
value much closer to the V1/2 of 1B-1- than 1A-2-contain-
ing channels. Since we only examined this inactivation
parameter with 20-s conditioning pulses, which might not
be not long enough to reach true steady-state inactivation, it
is possible that the observed differences in the V1/2 values
may reflect changes in the rate of inactivation rather than
changes in the V1/2 for steady-state inactivation.
It has been reported that four conserved glutamate resi-
dues, located at homologous positions in the putative pore-
lining region (P-region) of each repeat of the 1 subunit, are
molecular determinants for ion selectivity and ion perme-
ation of voltage-gated Ca2 channels (Yang et al., 1993;
Tang et al., 1993; Kim et al., 1993). The effect of the amino
FIGURE 6 Mutants 1AE1740R or 1ANP alter the kinetic properties of Ca
2 channels. (A, C) Examples of current traces from 1AE1740R2b1b
or 1ANP2b1b Ca
2 channels transiently expressed in HEK293 cells to test potentials between 50 and 10 mV in 10-mV increments. (B) The
voltage-dependence of channel activation is similar for 1AE1740R or 1ANP-containing channels, but the current magnitude is significantly increased
with 1AE1740R. Current-voltage relationships for 1AE1740R and 1ANP were constructed from 12 and 9 cells, respectively. Data points represent
mean  SE. (D) Comparison of activation and inactivation kinetics of Ca2 channels containing 1A/B(f), 1AE1740R, or 1ANP with those containing
wt 1A-2. The rates of activation and inactivation are significantly increased for 1A/B(f) and 1ANP compared to wt 1A-2 currents (open arrow) and are
only marginally different for 1AE1740R. Currents were elicited by step depolarizations to 10 mV from a holding potential of 90 mV. For comparison,
traces were normalized and superimposed.
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acid substitutions on ion selectivity outside the P-region, in
the 1A/B(f) or 1AE1740R subunits, were evaluated. The
interaction of Ca2 ions with the mutant Ca2 channels was
assessed by examining the Ca2 block of inward Na
current. Fig. 8 B illustrates current-voltage relationships of
Ca2 and Na currents from channels containing the
1A/B(f). In the absence of external Ca
2 (120 mM Na) the
current magnitude increased by 1.8-fold and the reversal
potential (Erev) shifted from 62 mV in the presence of
Ca2 (15 mM Ca2, 120 mM Na) to 2 mV. A similar
shift in Erev has been observed with channels containing the
rabbit 1C subunit expressed in Xenopus oocytes (Yang et
al., 1993). The inward Na current was reduced by 98% in
the presence of 300 M Ca2 without shifting Erev, indi-
cating the block of the Na current in the presence of
micromolar concentrations of Ca2 (Fig. 8 B, inset). Similar
results were observed with channels containing the
1AE1740R subunit (data not shown), suggesting that this
mutation does not alter permeation properties.
-Aga IVA inhibits 1ANP more effectively than
wt 1A
Finally, we also examined the effects of -Aga IVA on
Ca2 channels containing wt 1A-2, 1A/B(f), 1AE1740R, or
FIGURE 7 Comparison of inactivation kinetics of Ca2 channels containing 1A-2, 1B-1, 1A/B(f), or mutant 1AE1740R. (A–D) Currents were recorded
from HEK293 cells transiently expressing 2b1b and 1A-2, 1B-1, 1A/B(f), 1AE1740R, or 1ANP. All traces, except for 1AE1740R, were fitted to a
biexponential function of the form I  A0  A1 exp(t/1)  A2 exp(t/2). The values for 1 and 2 are indicated in Table 1. Holding potential: 90 mV.
TABLE 1 Comparison of inactivation kinetics of wt 1A, wt 1B, 1A/B(f), or 1A E1740R containing Ca
2 channels
wt 1A wt 1B 1A/B(f) 1A NP E1740R
1 179  36 ms 89  13 ms 78  25 ms 81  27 ms 347  207 ms
A1 62  18% 66  8% 72  14% 46  18% 69  12%
2 647  59 ms 508  220 ms 639  336 ms 418  119 ms —
A2 14  16% 26  4% 22  6% 41  19% —
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1ANP, since 1A-containing Ca
2 channels are sensitive
to block by this peptide toxin. At a concentration of 1 M,
-Aga IVA inhibited currents from 1A-2- or 1AE1740R-
containing channels to a similar degree and showed a sim-
ilar time course for the onset of block (54.6  12.6% and
61.9  16.9%; on: 254  44 and 204  26 ms; Fig. 9,
B–D). In contrast, the inhibition of 1ANP-containing
channels was substantially faster and more complete
(88.2  5.2%; on: 141  16 ms) whereas the block of
1A/B(f) was substantially slower and less complete (23.1 
3.0%, on: 647  286 ms; Fig. 9, B–D). The increase in
-Aga IVA sensitivity after removal of amino acids
N1655P1656 suggests that these two amino acids interfere
with the interaction of -Aga IVA and a binding side in the
IVS3-S4 linker. The role of this region for determining the
-Aga IVA sensitivity is supported by the finding that the
-Aga IVA sensitivity in 1A/B(f) is further reduced, where
NP and two additional neighboring amino acids are altered
(IAET1653–56, Fig. 4 A). However, an involvement of amino
acids within the IVS5-SS1 region that are also altered in
1A/B(f) cannot be ruled out.
In all cases, no relief from block by -Aga IVA was
observed by extended wash with toxin-free saline (10–20
min) or by 10 strong depolarizations (50-ms depolarization
to130 mV, 1 Hz). With increase in number and frequency
of strong depolarizations (50, 10 Hz) we obtained 5 
1.9% (n  3) relief from block for wt 1A-2 and 1ANP.
In two experiments with 1ANP we applied four and five
series of strong depolarizations (50, 10 Hz) and obtained
a cumulative relief of20 and 24%, respectively. The small
relief of block observed here with 1A-2- or 1ANP-con-
taining channels, even under conditions that allow pro-
longed channel openings at 130 mV, indicate a much
higher affinity for -Aga IVA in the open state of the
recombinant 1A channel than that observed with native
P-type Ca2 channels (McDonough et al., 1997a).
FIGURE 8 Isochronal inactivation
(h) of Ca
2 channels containing 1A-2,
1B-1, 1A/B(f), 1AE1740R, or 1ANP.
(A) Isochronal inactivation was ex-
pressed as the ratio of two test pulses to
10 mV, separated by a 20-s inactiva-
tion pulse to membrane potentials be-
tween 100 and 10 mV. Note the 10
mV hyperpolarizing shift in steady-state
inactivation with 1AE1740R, the 20
mV with 1ANP, and the 30 mV shift
with 1A/B(f) compared to the wt 1A-2.
Data were fitted by a Boltzmann func-
tion h  [1  exp(V  V1/2)/k]
1 and
best fits are shown as continuous lines
for 1A/B(f), E1740R, and 1ANP, and
as dashed lines for wt 1A-2 (see also
Fig. 1 F for original data) and 1B-1 (see
Fig. 4, Bleakman et al., 1995 for origi-
nal data). Values for V1/2/k are 59
mV/8.1 (1B-1), 42 mV/10.2
(1A/B(f)), 37 mV/7.3 (1ANP), 27
mV/7.6 (1AE1740R), and 17 mV/11
(1A-2). Data points represent mean 
SE, n  6 for all experiments. Holding
potential was 100 mV. (B) Inhibition
of Na currents through Ca2 channels
containing 1A/B(f) by low concentra-
tions of external Ca2. The current-volt-
age relationship for 1A/B(f) was ob-
tained with voltage-ramp protocol
(100 to80 mV in 300 ms). The inset
shows an enlarged scale of the current-
voltage relationship obtained with 120
mM Na  300 M Ca2 in the exter-
nal medium.
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DISCUSSION
Cloning and biophysical properties of human 1A
Ca2 channels
We have cloned two variants of the human 1A Ca
2
channel subunit. The two forms arise from alternative splic-
ing of human 1A Ca
2 channel transcripts, resulting in a
truncated COO-terminus of the 1A-2 isoform relative to
1A-1. Similar splicing has been observed with human BI
(Zhuchenko et al., 1997), rabbit BI (Mori et al., 1991), and
rat riA-1 (Ligon et al., 1998). Interestingly, the position of
the five-nt deletion in the human 1A that produces 1A-2
coincides with the position of the deletion in the human
1B-1 subunit that produces 1B-2 (Williams et al., 1992).
The mutations within the human 1A gene described by
Ophoff et al. (1996) that have been associated with two
neurological disorders, familial hemiplegic migraine and
episodic ataxia type-2, are not present in the two 1A
isoforms described here. Both variants described here con-
tain a two amino acid insert in the IVS3-S4 linker
(N1655P1656) that dramatically affects the biophysical and
pharmacological properties of the channel (see below). In
the rat 1A subunit, variants that contain the NP insert in the
IVS3-S4 linker have been recently described for the neuro-
nal (1A-b; Zamponi et al., 1996) and peripheral forms (Yu
et al., 1992; Ligon et al., 1998). In contrast, they are not
found in a human 1A cDNA (Zhuchenko et al., 1997) or the
genomic clones (Ophoff et al., 1996). Although one might
FIGURE 9 -Aga IVA inhibits 1ANP more potently than wt 1A-containing channels. (A) Representative current traces from wt 1A-2 and 1ANP
before (1) and 9.5 min after (2) application of 1 M -Aga IVA. Currents were elicited by step-depolarizations to 10 mV from a holding potential of
90 mV. (B) Time course of inhibition of normalized Ba2 current from wt 1A-2 (open circles) and 1ANP (filled circles). Horizontal bar: application
of 1 M -Aga IVA. The development of block followed an exponential function and the lines through the data points represent exponential fits with on
255 and 166 s for wt 1A-2 and 1ANP, respectively. The arrows indicate the time points for current shown in (A). (C) Maximum inhibition of Ba
2
currents by 1 M -Aga IVA measured after a 10-min application of 1 M -Aga IVA. (D) Comparison of on for -Aga IVA block of wt and mutant
channels. Values for on were determined as illustrated in (B). Data points in (C) and (D) represent mean  SE; wt 1A-2, 1ANP, 1AE1740R (n  5),
1A/B(f) (n  3).  and , values are significantly different at p 
 0.05 and p 
 0.001. All -Aga IVA-containing solutions also contained 1 mg/ml
cytochrome c.
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expect to find DNA sequence encoding the NP in the
genomic sequence, it is possible that an additional exon
encoding NP might be located in an as yet uncharacterized
region. These findings suggest that the neuronal human 1A
variants described here represent a previously unidentified
isoform of human 1A and could represent a splice variation
or a polymorphism of 1A.
The biophysical properties of human 1A-2-containing
Ca2 channels are similar to those reported for the rat and
rabbit homologs (Sather et al., 1993; Niidome et al., 1994;
Stea et al., 1994; De Waard and Campbell, 1995). One of
the most notable biophysical differences among human
1A-2, 1B-1, and 1E-3, each coexpressed with 2b and 1b
subunits, is that 1A-2-containing Ca
2 channels do not have
appreciable holding potential sensitivity in ranges relevant
to neurons (i.e., the V1/2 of isochronal inactivation (20 s) is
least negative for 1A-2-containing Ca
2 channels). Further-
more, the 1A-2-containing Ca
2 channels inactivate more
slowly. Both 1B-1- and 1E-3-containing channels are more
sensitive to changes in holding potential, and 1E-3-contain-
ing channels inactivate much more rapidly than 1A-2-con-
taining channels. All three of these recombinant channels
deactivate rapidly (	250 s), consistent with their classi-
fication as HVA Ca2 channels. This is also confirmed by
the positive half-maximal voltage of activation of these
three channels.
The half-maximal inactivation of the 1A-22b1b chan-
nels occurred at very positive potentials (V1/2  17.4
mV), indicating that these channels are most likely available
for activation during periods of low and high action poten-
tial frequency in neurons. By comparison, P-type Ca2
channels in rat cerebellar Purkinje cells or the rat 1A-
containing Ca2 channels are somewhat more sensitive to
holding potential (V1/234 and30.4 mV, respectively;
Regan et al., 1991; Berrow et al., 1997). Interestingly,
1ANP has a V1/2 value (37 mV) similar to that observed
with rat cerebellar P-type Ca2 channels. However, both the
P-type and the human 1A-22b1b Ca
2 channel do not
fully inactivate, with 10–15% residual current even at hold-
ing potentials of 0 mV or more positive. The V1/2 of
voltage-dependence of activation of the human 1A-con-
taining Ca2 channel was nearly 30 mV more positive than
the value obtained for the P-type Ca2 channel (Regan et
al., 1991). This difference may, in part, be explained by the
higher external Ba2 concentration used in the present study
(15 mM vs. 5 mM).
1A chimeras and mutations in domain IV alter
sensitivity to -Aga IVA
The block of human 1A-2-containing Ca
2 channels by
-Aga IVA was less complete compared to rat cerebellar
P-type Ca2 channels (Mintz et al., 1992b; McDonough et
al., 1997a) and was somewhat similar to that observed with
recombinant rat 1A expressed in COS-7 cells (Berrow et
al., 1997). One of the structural differences between the
human and rat 1A subunit is the N
1555P1556 insert in the
IVS3-S4 extracellular linker in human 1A that introduces
an additional polar residue (N). Removal of these residues
(1ANP) significantly increased the amount and speed of
block by -Aga IVA, whereas replacement of a charged
residue within the IVS5-SS1 extracellular linker in the
pore-forming region (E1740R) did not alter the toxin sen-
sitivity. This suggests that the addition of the NP residues
might sterically hinder the interaction of -Aga IVA with
its binding site or weaken the interaction by providing an
additional polar residue (N). This is consistent with the
reduced -Aga IVA block observed with 1A/B(f), which
contains an additional polar and an additional charged res-
idue to the IVS3-S4 linker (Fig. 4 A). However, 1A/B(f) also
contains amino acid changes in the IVS5-SS1 region, so it
is possible that these residues also affect the interaction of
-Aga IVA with the channel. Alternatively, the NP residues
may cause an allosteric effect on the binding of -Aga IVA.
Residues within the IVS3-S4 linker have been shown to
participate in binding of gating-modifier toxins to Na
(scorpion toxin; Rogers et al., 1996) and K channels
(hanatoxin; Swartz and MacKinnon, 1997b). Recently, Li-
Smerin et al. (1998) showed that drk1 K channels can also
interact with the gating-modifier toxin grammotoxin, a po-
tent P- and N-type Ca2 channel inhibitor (McDonough et
al., 1997a). Furthermore, binding of grammotoxin to drk1
K channels can be greatly reduced by altering residues
within the S3-S4 linker that also affect hanatoxin binding
(Swartz and MacKinnon, 1997a, b), and conversely, the
rabbit 1A Ca
2 channel can be inhibited by hanatoxin, a
selective K channel blocker. Based on their findings, Li-
Smerin et al. (1998) suggested that the S3-S4 linker contains
a conserved voltage-sensing structure that is recognized by
the gating modifier toxins. -Aga IVA has recently been
shown to inhibit cerebellar P-type Ca2 channels by mod-
ifying its gating mechanism (McDonough et al., 1997b).
Our findings with 1A/B(f) and 1ANP suggest that -Aga
IVA might interact with residues in the IVS3-S4 linker in
human 1A that are homologous S3-S4 linker in drk1 K

channels. The differences in the amino acid composition of
S3-S4 linker in the four domains of 1A Ca
2 channels and
the observation that grammotoxin binds to P-type Ca2
channels in the presence of -Aga IVA (McDonough et al.,
1997a) suggests that there are multiple heterogeneous toxin
binding sites in 1A. The selectivity of -Aga IVA for 1A
or P/Q-type Ca2 channels suggests further differences in
toxin binding sites between 1A and 1B Ca
2 channel. The
reduction in -Aga IVA block observed with 1A/B(f) sug-
gests that key residues of the toxin binding site are located
in IVS3-S4 linker (Fig. 4 B).
Localization of structural elements in domain IV
involved in controlling current magnitude
and inactivation
The two mutations in the 1A-2 subunit (1A/B(f),
1AE1740R) that resulted in increased current magnitude
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also resulted in a significant increase in the steady-state
protein levels of 1, 2b, and 1b subunits in cell mem-
branes. This possibly reflects an increase in the stability of
the complex within the membranes, the ability of the chan-
nel complex to incorporate into the plasma membrane, or
the strength of the interaction among the subunits. The
simplest explanation is that an increase in the number of
channels in membranes results in an increased current mag-
nitude. Increases in functional expression (or current mag-
nitude) of Ca2 channels containing rabbit 1C or rat 1B in
Xenopus oocytes by alteration of the primary sequence of
the 1 subunit have been reported previously. Functional
expression of recombinant Ca2 channels was increased by
partial deletion of the carboxyl terminus of the 1C subunit
or by partial exchange of the rat 1B subunit amino terminus
with the corresponding 1A sequence (Wei et al., 1994;
Ellinor et al., 1994). In the study by Ellinor et al. (1994) no
data were presented to explain the effect; however, Wei et
al. (1994) demonstrated that systematic deletions of increas-
ing portions in the 1C carboxy terminus resulted in an
increase in current magnitude without changes in unitary
conductance or charge movements during voltage-depen-
dent gating, suggesting an increase in channel open proba-
bility rather than an increase in number of channels in the
plasma membrane. This appears to be distinct from the
results with 1AE1740R and 1A/B(f), as changes in amino
acid sequence resulting in increased current magnitude in-
volve amino acids located in the extracellular region of
IVS3-IVSS1. Furthermore, in native cardiac L-type or re-
combinant human 1C-containing Ca
2 channels, intracel-
lular perfusion with proteolytic enzymes increased current
magnitude (Hescheler and Trautwein, 1988; Klockner et al.,
1995), a result similar to the enhancement observed with a
carboxyl terminal deletion mutant of the 1C subunit
(Klockner et al., 1995; Wei et al., 1994). However, this
mechanism may be specific to native cardiac L-type and
recombinant 1C-containing Ca
2 channels, as deletion of
the carboxy terminus in a recombinant skeletal muscle 1S
subunit failed to enhance Ca2 channel activity (Beam et
al., 1992). In a similar manner, no change in the magnitude
of Ba2 currents was observed in the present study after
substitution of the carboxy terminus of 1A-2 with the cor-
responding sequence of 1B-1. However, as none of the
tested mutations, which accounted for the most dramatic
differences in this region, resulted in the 30-fold increase in
current magnitude as observed with 1A/B(f), it is likely that
a combination of any or all of these amino acid differences
(81 possible combinations) may be necessary to achieve the
changes observed with 1A/B(f).
There are 20 amino acid differences between the 1A-2
and 1B-1 subunits in the 112 residue segment between
IVS3 and IVSS1. All differences occur in two putative
extracellular linkers next to the putative voltage sensor in
the S4 segment: the IVS3-S4 and the IVS5-SS1 linker.
Mutation in either one or both linker effected activation,
inactivation kinetics, and channel availability, indicating
that small changes in the local environment of the S4
segment are sufficient to significantly alter channel gating.
Previous studies identified several structural elements
within 1 subunits that are involved in Ca
2 channel acti-
vation or inactivation. For example, channel activation has
been associated with the IS3 segment and the IS3-S4 extra-
cellular linker in 1S-containing Ca
2 channels (Tanabe et
al., 1991; Nakai et al., 1994), whereas regulation of voltage-
dependent channel inactivation has been associated with the
IS6 and flanking regions in 1B-containing Ca
2 channels
(Zhang et al., 1994), and the IIISS2-S6, IVS5-SS2, or the
COO region in 1C-containing Ca
2 channels (Yatani et
al., 1994; Klockner et al., 1995). The findings with 1A/B(f),
1ANP, and 1AE1740R indicate the IVS3-S4 and IVS5-
SS1 linkers contain structural elements involved in regula-
tion of channel inactivation as well as activation.
Variation in the amino acid composition of the S3-S4
linker have previously been reported for N-type Ca2 chan-
nels from rat brain in domain III (rbB-I, rbB-II; Dubel et al.,
1994) and from superior cervical ganglion in domain IV
(Lin et al., 1997). These variants might be the result of
alternative splicing. Functional studies have shown that the
variants that lack either a four amino acid insert in IIIS3-S4
(-SMTP, rbB-II) or a two amino acid insert in IVS3-S4
linker (-ET, rb1B-d) activated and inactivated faster than
the variants containing the corresponding inserts. Sequence
alignment of the IVS3-S4 region from 1A and 1B reveals
that the NP insert found in human 1A occurs at a homol-
ogous position in rat 1B (Fig. 4 B). These findings suggest
that 1ANP may represent a genuine variant of human 1A
Ca2 channels. Furthermore, the splice variation of the
S3-S4 region(s) might be a general mechanism to control
channel gating of 1A or 1B Ca
2 channels, and perhaps
other voltage-gated channels. Changes in gating properties
of 1A or 1B Ca
2 channels that control neurotransmitter
release could significantly alter synaptic transmission, and
therefore may have profound physiological consequences.
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